The hypertensive disorders of pregnancy (29.3)

Magee, Laura A.; Pels, Anouk; Helewa, Michael; Rey, Évelyne; Dadelszen, Peter von; Audibert, François; Bujold, Emmanuel; Côté, Anne‐Marie; Douglas, M. Joanne; Eastabrook, Genevieve; Firoz, Tabassum; Gibson, Paul; Gruslin, Andrée; Hutcheon, Jennifer A.; Koren, Gideon; Lange, Ian; Leduc, Line; Logan, Alexander G.; MacDonell, Karen L.; Moutquin, Jean‐Marie; Sebbag, Ilana

doi:10.1016/j.bpobgyn.2015.04.001

Cited by 57 publications

(25 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[1][2][3] Maternal complications include eclampsia, renal and hepatic failure, placental abruption, and increased risk of chronic hypertension, cardiovascular disease, stroke, and metabolic syndrome later in life. 1,[4][5][6] Neonatal morbidities include complications associated with prematurity, along with increased risk of hypertension, diabetes, and neurological impairment later in their lives. 7,8 Traditionally, PE is considered a disease of the first pregnancy.…”

Section: Introductionmentioning

confidence: 99%

The role of placental histopathological lesions in predicting recurrence of preeclampsia

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

The role of placental histopathological lesions in predicting recurrence of preeclampsia

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Preeclampsia (PE), a pregnancy-specific disorder, is one of the most common obstetric disorders [1]. The global morbidity of PE is approximately 3-8%, and it is the leading cause of pregnancy-related maternal and neonatal morbidity and mortality worldwide [2].…”

Section: Introductionmentioning

confidence: 99%

CircRNA-0004904, CircRNA-0001855, and PAPP-A: Potential Novel Biomarkers for the Prediction of Preeclampsia

Jiang

Lash

Zhao

et al. 2018

Cell Physiol Biochem

View full text Add to dashboard Cite

Background/Aims: Circular RNAs (circRNAs) are transcribed prevalently in the genome; however, their potential roles in multiple cardiovascular diseases, particularly preeclampsia (PE), are not yet well understood. This study investigated the expression profiles of circRNAs and explored circRNA-mediated pregnancy-associated plasma protein A (PAPP-A) expression as a potential biomarker for PE before 20 weeks of pregnancy. Methods: A nested case-control two-phase screening/validation study was performed in pregnant women before 20 weeks of gestation (before clinical diagnosis) at Guangzhou Women and Children’s Medical Center from 2012 to 2015. In the screening phase, circRNA expression profiles of blood cells were assessed using a human circRNA microarray, which was designed to detect simultaneously 5396 circRNAs, in 5 patients with PE and 5 age- and gestational week-matched controls. In the validation phase, 18 circRNAs in blood cells predicted by bioinformatics tools were validated by quantitative reverse transcription PCR in a cohort of 60 patients (PE and age-, gestational week-, and sample storage time-matched controls). Then, we examined the involvement of circRNAs in PE-related pathways via interactions with miRNAs by multiple bioinformatics approaches. Bioinformatics analysis predicted that hsa_circ_0004904 and hsa_circ_0001855 miRNA sponges directly target PAPP-A. PAPP-A was verified in the serum of the same cohort of patients using an enzyme-linked immunosorbent assay. Finally, we combined PAPP-A with circRNAs to create a novel preclinical diagnostic model for PE with logistic regression and evaluated the efficiency of this model with receiver operating curve analysis. Results: Volcano plot analysis using various parameters showed that circRNAs were differentially expressed among both groups (P < 0.01, fold change > 2). In the screening phase, we found that 2178 circRNAs were differentially expressed between the control and PE groups, in which 884 circRNAs were downregulated and 1294 circRNAs were upregulated in the PE group compared with the control group. In the validation phase, two circRNAs, hsa_circ_0004904 and hsa_circ_0001855, were significantly upregulated in PE patients compared with healthy pregnant women (P < 0.05). PAPP-A expression levels, related to the two circRNAs based on bioinformatics prediction, were increased in the PE group compared with the control group. The area under the curve of the combined model was 0.94 in the predicted PE subjects. Conclusions: This is the first study to report circRNA profiling in patients with PE prior to the onset of symptoms. Our data suggested that hsa_circ_0004904 and hsa_circ_0001855 combined with PAPP-A might be promising biomarkers for the detection of PE. Moreover, circRNAs may provide new insights into the potential mechanisms underlying the pathophysiology of PE.

show abstract

“…Hypertensive disorders in pregnancy are the most common cause of maternal morbidity and mortality and occur in approximately 10% of pregnancies. 5 PHD has been associated with long-term poor health outcomes, including stroke, ischemic heart disease, and, more recently, Alzheimer's disease. 6 The underlying etiology of this increased risk is not entirely clear, although mechanisms such as endothelial dysfunction or dysfunction of the renin-angiotensin system have been postulated.…”

Section: Should a History Of Assisted Reproductive Technology Be Anotmentioning

confidence: 99%

“…Hypertensive disorders in pregnancy are the most common cause of maternal morbidity and mortality and occur in approximately 10% of pregnancies . PHD has been associated with long‐term poor health outcomes, including stroke, ischemic heart disease, and, more recently, Alzheimer's disease .…”

mentioning

confidence: 99%

Should a history of assisted reproductive technology be another consideration when assessing cardiovascular risk?

Goldstein

Callegari

2016

J of Clinical Hypertension

View full text Add to dashboard Cite

The hypertensive disorders of pregnancy (29.3)

Cited by 57 publications

References 51 publications

The role of placental histopathological lesions in predicting recurrence of preeclampsia

The role of placental histopathological lesions in predicting recurrence of preeclampsia

CircRNA-0004904, CircRNA-0001855, and PAPP-A: Potential Novel Biomarkers for the Prediction of Preeclampsia

Should a history of assisted reproductive technology be another consideration when assessing cardiovascular risk?

Contact Info

Product

Resources

About